Overdose deaths and opioid use have risen significantly in the United States, with research indicating that the risk of opioid use and overdose fatality is higher in construction than in other industries. With the March 2023 Food and Drug Administration’s (FDA) approval of the first over-the counter opioid-reversal drug Naloxone nasal spray, particularly the nasal-spray brand name Narcan, it is becoming more widely available and prevalent on construction sites.
Join Kevin Cannon from AGC of America (moderator), Mandi Kime from AGC of Washington, and Janice Hartgens from National Safety Council on November 16, 2PM - 3PM Eastern, as they unpack the state of opioid use/misuse in construction and things you should know about Naloxone/Narcan – what it is and how it works, obtaining naloxone/NARCAN, workplace readiness, legal and liability concerns, policies and procedures on responding to opioid overdose, and much more.